Abstract
Obesity (body mass index (BMI) above 30 kg/m2) has become an epidemic condition that affects 10–27% of men and up to 38% of women in European countries. In the United States, more than 5% of the adult population are considered morbidly obese (BMI of 40 kg/m2 or more). Worldwide, more than 300 million people are estimated to be obese. According to recent epidemiologic studies, greater BMI, greater weight, larger waist circumference, and heavy weight gain are independently associated with increased risk for renal stone formation. This appears to be related to two distinct metabolic conditions: (1) Abdominal obesity in the context of the so-called metabolic syndrome predisposes to insulin resistance, which at the renal level appears to cause reduced urinary ammonium excretion and low urine pH. The consequence is an increased risk for uric acid stone formation. (2) Bariatric surgery, more and more popular as the only intervention that facilitates significant weight loss in morbidly obese people, has been shown to increase the risk for calcium oxalate nephrolithiasis. The underlying pathophysiologic mechanisms may be enteric hyperoxaluria due to fat malabsorption or decreased intestinal colonization with oxalate-degrading bacteria.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356:2176-2183.
James WPT, Van de Werf F. Obesity management: the cardiovascular benefits. Eur Heart J. 2005;7(Suppl L):L3-L4.
Flum DR, Khan TV, Dellinger EP. Toward the rational and equitable use of bariatric surgery. JAMA. 2007;298:1442. commentary.
Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455-462.
Powell CR, Stoller ML, Schwartz BF, et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 2000;55:825-830.
Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905-915.
Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CYC. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004;65:1422-1425.
Hess B. Acid-base metabolism: implications for kidney stone formation. Urol Res. 2006;34:134-138.
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817-1823.
Hesse A, Brändle E, Wilbert, Köhrmann K-U, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003;44:709-713.
Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet. 2005;366:1059-1062.
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis. 2008;51:741-747.
Pak CYC, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int. 2001;60:757-761.
Kamel KS, Cheema-Dhadli S, Halperin ML. Studies on the pathophysiology of the low urine pH in patients with uric acid stones. Kidney Int. 2002;61:988-994.
Sakhaee S, Adams-Huet B, Moe OW, Pak CYC. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int. 2002;62:971-979.
Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65:386-392.
Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association; National Heart, Lung, and Blood Institute, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005;112:2735-2752.
Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes. 1996;45:633-638.
DeFronzo RE, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;233:E214-E223.
Sinha MK, Collazo-Clavell ML, Rule A, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y-gastric bypass surgery. Kindey Int. 2007;71:100-107.
DePrisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci. 2005;329:57-61.
Colazzo-Clavell ML, Jiminez A, Hodgson SF, Sarr MG. Osteomalacia after Roux-en-Y-gastric bypass. Endocr Pract. 2004;10:195-198.
Shinogle JA, Owings MF, Kozak LJ. Gastric bypass as treatment for obesity: trends, characteristics, and complications. Obes Res. 2005;13:2202-2209.
Nelson WK, Houghton SG, Milliner DS, Lieske JC, Sarr MG. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1:481-485.
Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007;177:565-569.
Duffey BG, Pedro RN, Mahklouf A, et al. Roux-en-Y gastric bypass is associated with early increased risk factors for development of caclium oxalate nephrolithiasis. J Am Coll Surg. 2008;206:1145-1153.
McLeod RS, Churchill DN. Urolithiasis complicating inflammatory bowel disease. J Urol. 1992;148:974-978.
Siener R, Ebert D, Hesse A. Urinary oaxalate excretion in female calcium oxalate stone formers with and without a history of recurrrent urinary tract infections. Urol Res. 2001;29:245-248.
Allison MJ, Cook HM, Milne DB, et al. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr. 1986;116:455-460.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer London
About this chapter
Cite this chapter
Hess, B. (2010). Obesity, Metabolic Syndrome, and Stones. In: Rao, N., Preminger, G., Kavanagh, J. (eds) Urinary Tract Stone Disease. Springer, London. https://doi.org/10.1007/978-1-84800-362-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-84800-362-0_9
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84800-361-3
Online ISBN: 978-1-84800-362-0
eBook Packages: MedicineMedicine (R0)